No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:66480800-66490600 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
2 |
chr17:66486200-66488600 |
Enhancers |
GM12878-XiMat |
blood
|
3 |
chr17:66486200-66488800 |
Enhancers |
Primary B cells from cord blood |
blood
|
4 |
chr17:66486200-66488800 |
Enhancers |
Fetal Muscle Leg |
muscle
|
5 |
chr17:66486200-66488800 |
Enhancers |
Lung |
lung
|
6 |
chr17:66486400-66488600 |
Enhancers |
Spleen |
Spleen
|
7 |
chr17:66486400-66488800 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
8 |
chr17:66486400-66488800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
9 |
chr17:66486800-66488600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
10 |
chr17:66487000-66488600 |
Enhancers |
Brain Substantia Nigra |
brain
|
11 |
chr17:66487000-66488800 |
Enhancers |
Placenta |
Placenta
|
12 |
chr17:66487000-66489600 |
Enhancers |
Skeletal Muscle Male |
skeletal muscle
|
13 |
chr17:66487200-66493800 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
14 |
chr17:66487400-66489000 |
Enhancers |
Fetal Muscle Trunk |
muscle
|
15 |
chr17:66487600-66488800 |
Enhancers |
Fetal Heart |
heart
|
16 |
chr17:66487600-66489400 |
Enhancers |
Left Ventricle |
heart
|
17 |
chr17:66487800-66488600 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
18 |
chr17:66487800-66488600 |
Enhancers |
Fetal Thymus |
thymus
|
19 |
chr17:66487800-66488600 |
Enhancers |
Skeletal Muscle Female |
skeletal muscle
|
20 |
chr17:66488000-66488600 |
Flanking Active TSS |
Colonic Mucosa |
Colon
|
21 |
chr17:66488000-66488600 |
Flanking Active TSS |
Duodenum Mucosa |
Duodenum
|
22 |
chr17:66488000-66488600 |
Flanking Active TSS |
Pancreas |
Pancrea
|
23 |
chr17:66488000-66488600 |
Flanking Active TSS |
Rectal Mucosa Donor 29 |
rectum
|
24 |
chr17:66488000-66488600 |
Active TSS |
Rectal Smooth Muscle |
rectum
|
25 |
chr17:66488000-66488600 |
Bivalent Enhancer |
HepG2 |
liver
|
26 |
chr17:66488000-66489000 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
27 |
chr17:66488200-66488600 |
Enhancers |
Brain Hippocampus Middle |
brain
|
28 |
chr17:66488200-66489400 |
Weak transcription |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
29 |
chr17:66488200-66493400 |
Weak transcription |
Primary B cells from peripheral blood |
blood
|
30 |
chr17:66488200-66493800 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
31 |
chr17:66488200-66494600 |
Weak transcription |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
32 |
chr17:66488400-66488600 |
Flanking Bivalent TSS/Enh |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
33 |
chr17:66488400-66488600 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
34 |
chr17:66488400-66488600 |
Flanking Bivalent TSS/Enh |
NHEK |
skin
|
35 |
chr17:66488400-66488800 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
36 |
chr17:66488400-66488800 |
Weak transcription |
Liver |
Liver
|
37 |
chr17:66488400-66488800 |
Enhancers |
Esophagus |
oesophagus
|
38 |
chr17:66488400-66488800 |
Flanking Active TSS |
Rectal Mucosa Donor 31 |
rectum
|
39 |
chr17:66488400-66489200 |
Weak transcription |
Right Atrium |
heart
|
40 |
chr17:66488400-66489400 |
Weak transcription |
Fetal Lung |
lung
|
41 |
chr17:66488400-66489400 |
Weak transcription |
Fetal Stomach |
stomach
|
42 |
chr17:66488400-66490000 |
Enhancers |
Adipose Nuclei |
Adipose
|
43 |
chr17:66488400-66493800 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
44 |
chr17:66488400-66494400 |
Weak transcription |
Ovary |
ovary
|
45 |
chr17:66488400-66494600 |
Weak transcription |
Gastric |
stomach
|